Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets. (2020)

First Author: Sierksma A
Attributed to:  Molecular Genetic Studies of Schizophrenia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.abb8575

PubMed Identifier: 33004512

Publication URI: http://europepmc.org/abstract/MED/33004512

Type: Journal Article/Review

Volume: 370

Parent Publication: Science (New York, N.Y.)

Issue: 6512

ISSN: 0036-8075